Exome sequencing (ES) identified compound‐heterozygous loss‐of‐function variants in the candidate gene RBL2 segregating within the family proposing RBL2 as an excellent candidate gene for neurodevelopmental disorders. Here, RBL2 is linked to neurodevelopmental disorder.